Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
18.36
+0.44 (2.46%)
At close: Feb 17, 2026, 4:00 PM EST
17.99
-0.37 (-2.02%)
After-hours: Feb 17, 2026, 4:28 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.45 billion as of February 17, 2026. Its market cap has increased by 266.95% in one year.
Market Cap
1.45B
Enterprise Value
1.12B
1-Year Change
266.95%
Ranking
Category
Stock Price
$18.36
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.45B, an increase of 72.02%. That is a compound annual growth rate of 12.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.42B | 39.00% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.51B |
| Tyra Biosciences | 1.49B |
| AnaptysBio | 1.47B |
| Zenas BioPharma | 1.42B |
| Novavax | 1.41B |
| Savara | 1.38B |
| Intellia Therapeutics | 1.37B |
| Kodiak Sciences | 1.37B |